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Volume 58, Number 2 Abstracts 551Summary: Transfusion is increasingly recognized as a potential risk
factor for adverse patient outcomes. In cardiac surgery in particular, perio-
perative transfusion of packed red blood cells (RBCs) has been associated
with increased mortality, postoperative ischemic morbidity, increased cost,
and increased severe postoperative bacterial infections (Leal-Noval SR,
Chest 2001;119:1461-8). Data on the effect of transfusion in vascular
surgical patients after vascular surgical procedures are less robust than that
after cardiac surgery. In this study, the authors used the Vascular Study
Group of New England database to examine patients with LEB. Speciﬁcally,
they sought to analyze the association of intraoperative and postoperative
blood transfusion with 30-day and midterm outcomes that included patient
survival, wound infection, and LEB graft patency. The Vascular Study
Group of New England database was queried from 2003 to 2010 for
LEB operations. There were 1880 infrainguinal LEBs performed for critical
limb ischemia. Perioperative transfusion was categorized as 0 units (U), 1 to
2 U, and $3 U. Cohort frequency group matching was used to compare
patients receiving 1 to 2 U or 0 U with patients receiving$3 U. Corrections
were for age, coronary artery disease, diabetes, urgency, and indication of
revascularization. Primary end points were perioperative mortality, wound
infection, and loss of primary graft patency at discharge; 1-year mortality;
and loss of primary graft patency during the ﬁrst postoperative year. There
were 1532 LEBs (81.5%) that received 0 U of transfusion, 248 LEBs
(13.2%) that received 1 to 2 U, and 100 LEBs (5.3%) that received $3
U. In the study cohort and group frequency-matched cohort, transfusion
was associated with higher perioperative wound infection of 4.8% for 0 U
vs 6.5% for 1 to 2 U vs 14.0% $3 U (P ¼ .0004) and was also associated
with graft thrombosis at discharge of, respectively, 4.5% vs 7.7% vs 15.3%
(P < .0001). No differences in infection or graft patency were noted at 1
year. Multivariate analysis showed transfusion was independently associated
with increased perioperative wound infection in the study cohort and group
frequency-matched cohort (1 to 2 U vs 0 U: adjusted odds ratio [OR], 1.4;
95% conﬁdence interval [CI], 0.8-2.5; P ¼ .263; $3 U vs 0 U: OR, 3.5;
95% CI, 1.8-6.7; P ¼ .0002; overall P ¼ .002). Finally, transfusion was asso-
ciated with graft thrombosis at discharge (1 to 2 U vs 0 U: OR, 2.1; 95% CI,
1.2-3.6; P ¼ .01; $3 U vs 0 U: OR, 4.8; 95% CI, 2.5-9.2; P < .0001; over-
all P < .0001).
Comment: This is one of the ﬁrst studies to look at the signiﬁcance of
transfusion in LEB patients. However, despite the excellent statistical meth-
odology used, this is still a retrospective study of voluntarily contributed
data. It is not a randomized controlled trial. Therefore, we do not truly
know whether there are unknown confounders associated with the adjust-
ments that might contribute to a greater degree in the statistical outcome
of one group vs another. The very fact that patients receiving transfusions,
especially $3 U, also lost more blood, despite matching other characteris-
tics, strongly suggest there may be something different about the operations
that had increased transfusions vs those that did not.A Risk Factor-Based Predictive Model of Outcomes in Carotid
Endarterectomy: The National Surgical Quality Improvement
Program 2005-2010
Bekelis K, Bakhoum SF, Desai A, et al. Stroke 2013;44:1085-90.
Conclusion: Patient-level characteristics dramatically inﬂuence risk of
carotid endarterectomy (CEA). Models based on patient-level characteris-
tics, however, cannot be used for individual patient risk assessment because
of limited discriminatory ability.
Summary: Results of the randomized trials of CEA directly apply only
to those meeting inclusion and exclusion criteria for the trials. Patients were
generally considered to have had low overall operative risk and to have met
predeﬁned age ranges for inclusion in the trials. It would be useful to
compare estimated risk of adverse events in individual patients in routine
clinical practice with benchmarks for the performance of CEA. Studies in
the past have generally been retrospective analysis of individual institutional
experiences, thus limiting general applicability because of inherent selection
bias. The American College of Surgeons (ACS) National Quality Improve-
ment Program (NSQIP) database contains prospective data from >180
private and academic hospitals across the United States. The authors used
this database to develop a risk factor-based predictive model of negative
outcomes for CEA. The hope is to better quantify risk of the individual
patient being considered for CEA. This was a retrospective cohort studyinvolving patients undergoing CEA from 2005 to 2010 who were registered
in NSQIP. There were 35,698 CEA patients: 20,015 (56.15%) were asymp-
tomatic and 15,683 (43.9%) were symptomatic. At 30 days after CEA,
patients demonstrated a 1.64% stroke risk, 0.69% risk of myocardial infarc-
tion (MI), and a 0.75% risk of death. Multivariate analysis indicated male
sex, increased age, history of chronic pulmonary disease, MI, congestive
heart failure, peripheral vascular disease, previous stroke, transient ischemic
attack, and dialysis-dependence were all independent risk factors associated
with an increased risk of the combined outcome of postoperative stroke,
MI, or death after CEA. A validated model for outcome prediction based
on individual patient characteristics was developed. There was a steep effect
of age on the risk of MI and death. Additional analysis indicated the model
could predict the risk of stroke, MI, death, or the composite outcome for
patients in the NSQIP cohort. However, the model exhibited only modest
discrimination, with an inadequate C statistical value indicating that it
cannot be used for individual patient decision making.
Comment: One might ask if the model cannot be used to help make
individual decisions for patients, of what use is the model? The primary use
would appear to be development of risk-prediction models for populations
of patients, individual hospitals, or health care systems. The model, there-
fore, may be used for risk predications for patient populations and therefore
could provide an objective bases for observed to expected complication
rates.Trends in Treatment of Ruptured Abdominal Aortic Aneurysm:
Impact of Endovascular Repair and Implications for Future Care
Park BD, Azefor N, Huang C-C, et al. J Am Coll Surg 2013;216:745-55.
Conclusions: Endovascular repair of ruptured abdominal aortic aneu-
rysm (RAAA) is more common in urban teaching hospitals and is associated
with reduced mortality and complications across all age groups. No therapy
for RAAA is more common in rural hospitals.
Summary: Marin et al reported endovascular aneurysm repair
(EVAR) for RAAA in 1994 (Ann Surg 1995;222:449-65). Since that
time, a number of anecdotal series have suggested that at an individual insti-
tution level, EVAR can result in decreased mortality associated with RAAA,
and EVAR for repair of RAAA is being used with increased frequency across
the United States during the last decade. In this report, the authors sought
to document recent trends in the management of RAAA in the United
States. They speciﬁcally wished to examine use of EVAR for treatment of
RAAA and to draw some implications from these ﬁndings for future care
of patients with RAAA. Data for this study were obtained from the Nation-
wide Inpatient Sample from 2005 to 2009. Identiﬁed patients aged >59
years with RAAA were included. Three groups were studied: nonoperative
(NO), EVAR, and open surgical repair (OSR) for RAAA. The relationship
between treatment type, patient demographics, clinical characteristics, and
hospital type was determined with c2 analysis. Logistic regression analysis
was used to examine EVAR compared with OSR on mortality and overall
complications of RAAA. Of 21,206 patients with RAAA identiﬁed from
2005 to 2009, 16,558 (78.1%) underwent operative repair and 21.8%
received no operative treatment. Among the operatively treated patients,
12,761 (71.1%) underwent OSR and 3,796 (22.9%) underwent EVAR.
EVAR was more common in teaching hospitals (29.1% vs 15.2%, P <
.0001) and in urban vs rural settings. In the rural setting, a nonoperative
approach was twice as common as in the urban setting. Reduced mortality
was seen in patients transferred from one institution to another (31.2% v
39.4%, P ¼ .014). EVAR was associated with a lower complication rate
(odds ratio, 0.492; conﬁdence interval, 0.380-0.636) and decreased
mortality (odds ratio, 0.535; conﬁdence interval, 0.395-0.724).
Comment: The authors believe EVAR should be offered whenever
possible to patients with RAAA. However, like any retrospective series, these
data are subject to potentially heavy selection bias. In addition, a number of
parameters associated with operative mortality for RAAA cannot be
analyzed with the Nationwide Inpatient Sample database. These include
shock, oliguria, and preoperative state of consciousness. Nevertheless, the
data do provide a snapshot of the state of RAAA repair in the United States
and suggest mortality may be reduced through increasing the use of EVAR
for treatment of RAAA. In addition, the number of turndowns for repair of
RAAA may be able to be reduced by more efﬁcient transportation systems
to centers of excellence that use EVAR for treatment of RAAA.
